Peptides and compounds that bind to a thrombopoietin receptor
US6083913A · kind A · utility
34Cited by
4References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 4, 1997 |
| Grant date | Jul 4, 2000 |
| Priority date | — |
| Expiry date | Dec 4, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Receptors are peptides and peptide mimetics that bind to and activate the thrombopoietin receptor. Such peptides and peptide mimetics are useful in methods for treating hematological disorders and particularly, thrombocytopenia resulting from chemotherapy, radiation therapy, or bone marrow transfusions as well as in diagnostic methods employing labeled peptides and peptide mimetics.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.